| Manager, Economic Modelling |
Hyderabad (Office) |
India |
Operations |
Universal Hierarchy Node |
Market Access |
May 20, 2025 |
| Pricing Director |
Basel (City) |
Switzerland |
International |
Innovative Medicines |
Market Access |
May 20, 2025 |
| Regional Dir, Access & Reimbursement NPS -Immunology- Central- Remote |
Field Non-Sales (USA) |
USA |
US |
Universal Hierarchy Node |
Market Access |
May 19, 2025 |
| Value & Access Lead |
Riyadh |
Saudi Arabia |
International |
Innovative Medicines |
Market Access |
May 15, 2025 |
| International HEOR TA Head (3 open roles) |
Basel (City) |
Switzerland |
International |
Innovative Medicines |
Market Access |
May 14, 2025 |
| Director, Access International |
Basel (City) |
Switzerland |
Finance |
Innovative Medicines |
Market Access |
May 13, 2025 |
| Patient Access Lead Lithuania |
Lithuania |
Lithuania |
International |
Innovative Medicines |
Market Access |
May 13, 2025 |
| Launch Excellence Manager |
Amsterdam |
Netherlands |
International |
Innovative Medicines |
Market Access |
May 08, 2025 |
| Solution & Service Design Manager |
London (The Westworks) |
United Kingdom |
International |
Universal Hierarchy Node |
Market Access |
May 08, 2025 |
| Launch Excellence Lead |
Amsterdam |
Netherlands |
International |
Innovative Medicines |
Market Access |
May 08, 2025 |
| Senior Manager, Evidence Generation |
Hyderabad (Office) |
India |
Operations |
Universal Hierarchy Node |
Market Access |
May 08, 2025 |
| Senior Manager, Economic Modelling |
Hyderabad (Office) |
India |
Operations |
Universal Hierarchy Node |
Market Access |
May 06, 2025 |
| Supervisor Program Management Float |
INSURGENTES |
Mexico |
US |
Innovative Medicines |
Market Access |
May 02, 2025 |
| Director, Market Access Strategy- RLT (Radioligand Therapy) |
Distant Employee - Distant Working Arrangement (DWA) (USA) |
USA |
US |
Universal Hierarchy Node |
Market Access |
May 01, 2025 |
| HTA Evidence Synthesis Statistician (2 open roles) |
London (The Westworks) |
United Kingdom |
International |
Universal Hierarchy Node |
Market Access |
Apr 28, 2025 |
| Expert médico-économie / HEOR - H/F |
Paris Headquarter (Novartis Pharma S.A.S.) |
France |
International |
Innovative Medicines |
Market Access |
Apr 22, 2025 |
| Associate Director, Access Solutions |
London (The Westworks) |
United Kingdom |
Corporate Affairs |
Universal Hierarchy Node |
Market Access |
Apr 16, 2025 |
| (Sr.) Healthcare Solutions Manager |
Taipei |
Taiwan |
International |
Innovative Medicines |
Market Access |
Apr 09, 2025 |
| Value & Access Brand Lead |
London (The Westworks) |
United Kingdom |
International |
Innovative Medicines |
Market Access |
Apr 09, 2025 |
| HEOR Manager |
London (The Westworks) |
United Kingdom |
International |
Universal Hierarchy Node |
Market Access |
Apr 02, 2025 |
| Pricing & Reimbursement Lead |
Seoul |
South Korea |
International |
Innovative Medicines |
Market Access |
Apr 01, 2025 |
| Manager, Market Access Contracting - Remote |
Remote Position (USA) |
USA |
US |
Universal Hierarchy Node |
Market Access |
Mar 31, 2025 |
| Market Access Manager |
Moscow (City) |
Russian Fed. |
International |
Innovative Medicines |
Market Access |
Mar 28, 2025 |
| Patient Access Lead |
Kyiv |
Ukraine |
International |
Innovative Medicines |
Market Access |
Mar 27, 2025 |
| AD, Access & Reimbursement RLT - Los Angeles, CA - Remote |
Field Non-Sales (USA) |
USA |
US |
Universal Hierarchy Node |
Market Access |
Mar 27, 2025 |
| Field Technical Expert (Radio Ligand Therapy) |
Toranomon (NPKK Head Office) |
Japan |
International |
Innovative Medicines |
Market Access |
Mar 23, 2025 |
| Regional Access Lead |
Kerala |
India |
International |
Universal Hierarchy Node |
Market Access |
Mar 09, 2025 |
| Regional Access Lead |
Rajasthan |
India |
International |
Universal Hierarchy Node |
Market Access |
Mar 09, 2025 |
| Lead, Pricing & Public Policy |
Toranomon (NPKK Head Office) |
Japan |
International |
Innovative Medicines |
Market Access |
Jan 28, 2025 |
| New Products & Strategic Pricing Partner |
Kyiv |
Ukraine |
International |
Innovative Medicines |
Market Access |
Apr 16, 2024 |